Diederik Stapel is up to 49 retractions.
Here are the latest three, from Personality and Social Psychology Bulletin: Continue reading “When we wonder what it all means”: Stapel retraction count rises to 49
Category: clinical study retractions
Retraction 46 arrives for Diederik Stapel
Diederik Stapel has a new retraction, his 46th.
Here’s the notice for “The effects of diffuse and distinct affect. ” by Diederik A. Stapel, Willem Koomen and Kirsten I. Ruys, which appeared in the Journal of Personality and Social Psychology in 2002: Continue reading Retraction 46 arrives for Diederik Stapel
Study of blood pressure drug valsartan retracted
Hiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.
As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Continue reading Study of blood pressure drug valsartan retracted
ORI says Case Western skin scientist falsified data
The U.S. Office of Research Integrity has sanctioned Bryan William Doreian, a former postdoc in dermatology at Case Western Reserve University in Cleveland, for falsifying data in his dissertation and a 2009 paper in Molecular Biology of the Cell (for which it provided a cover image, at right).
ORI says Doreian’s bad NIH-funded data also appeared in a manuscript submitted to, but never published in, Nature Medicine.
Here are the papers cited in the finding: Continue reading ORI says Case Western skin scientist falsified data
“Unreliable” findings fell TB gene study in PLOS ONE
Here’s a nice example of how science should work.
A team of Swiss microbiologists has retracted their 2012 paper in PLoS One on the genetics of the TB mycobacterium after learning that the fusion protein they thought they’d used in their study was in fact a different molecule.
Here’s the retraction notice for the article, “A β-lactamase based reporter system for ESX dependent protein translocation in mycobacteria,” which has been cited once, according to Thomson Scientific’s Web of Knowledge: Continue reading “Unreliable” findings fell TB gene study in PLOS ONE
Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction
A new study in Clinical Chemistry paints an alarming picture of how often scientists deposit data that they’re supposed to — but perhaps not surprisingly, papers whose authors did submit such data scored higher on a quality scale than those whose authors didn’t deposit their data.
Ken Witwer, a pathobiologist at Hopkins, was concerned that a lot of studies involving microarray-based microRNA (miRNA) weren’t complying with Minimum Information About a Microarray Experiment (MIAME) standards supposedly required by journals. So he looked at 127 such papers published between July 2011 and April 2012 in journals including PLOS ONE, the Journal of Biological Chemistry, Blood, and Clinical Chemistry, assigning each one a quality score and checking whether the authors had followed guidelines.
What he uncovered wasn’t pretty — and has already led to a retraction. From the abstract: Continue reading Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction
Lyme disease diagnostics review retracted for plagiarism
A review paper published in the Serbian journal Medicinski pregled (Medical review) has been retracted for plagiarising a 2002 paper published in the Croatian Journal of Infection (or Infektološki glasnik).
The retraction note (in Serbian only) in the current issue (vol. 65, issue 11-12) of Medicinski pregled, published by the Society of Physicians of Vojvodina of the Medical Society of Serbia reads: Continue reading Lyme disease diagnostics review retracted for plagiarism
Stapel watch reaches 45 retractions
Keeping up with the retraction count of Diederik Stapel is proving to be a, well, staple of this job. Four more retractions brings the figure to 45.
The articles in question are: Continue reading Stapel watch reaches 45 retractions
McGill committee says Nature figures were “intentionally contrived and falsified”
An associate professor at Montreal’s McGill University is correcting two papers, one of them in Nature, after a university committee found evidence of falsification, Retraction Watch has learned.
Concerns had been raised about four papers by Maya Saleh and colleagues: Continue reading McGill committee says Nature figures were “intentionally contrived and falsified”
Correction for MD Anderson’s Aggarwal, cancer researcher whose work is under investigation
Bharat Aggarwal, the highly cited MD Anderson Cancer Center researcher who has confirmed to us that his work is under investigation by the institution, has a correction of his work in the Journal of Molecular Medicine. Troubled images are to blame — as they have been in previous retractions, and at least one other correction, of Aggarwal’s papers.
The paper, “Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor,” was published in December 2010 and cited 15 times since, according to Thomson Scientific’s Web of Knowledge.
Here’s the notice: Continue reading Correction for MD Anderson’s Aggarwal, cancer researcher whose work is under investigation